Intrathecal or epidural administration of 3-[(1S,25)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
AssigneeGruenenthal GmbH
InventorsPetra Bloms-Funke, Derek John Saunders, Eric Lang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of providing pain management in a subject wherein the administration of the composition does not result in any non-central nervous system mediated systemic effect in the subject. In particular, the present invention relates to a method of administering 3-[(1S,2S)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]-phenol in a space that is void of thrombocytes.
Claims14
A method of locally treating or inhibiting pain in a subject in need thereof comprising administering to said subject, in a space that is void of thrombocytes, a therapeutically effective amount of a composition comprising 3-[(1S,2S)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol or a physiologically acceptable salt thereof, whereby administration of said composition does not result in any peripherally or supraspinally mediated side effect in the subject.
Dependencies are inferred from the claim text.